Bryan M. LEWIS,Lawrence Tim FRIEDHOFF,Stephen Clement PISCITELLI,Kunal KISHNANI,Shankar RAMASWAMY
申请号:
MX2017014191
公开号:
MX2017014191A
申请日:
2016.05.06
申请国别(地区):
MX
年份:
2018
代理人:
摘要:
The present application relates to new uses of 5-HT6 receptor antagonists, specifically high doses of 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline, and to the combination of 5-HT6 receptor antagonists, specifically 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline, with, an acetylcholinesterase inhibitor for the treatment of a neurodegenerative disease.La presente solicitud se refiere a nuevos usos de antagonistas del receptor 5-HT6, específicamente dosis altas de 3-fenilsulfonil-8-piperazinil-lil-quinolina, y a la combinación de antagonistas del receptor 5-HT6, específicamente 3-fenilsulfonil-8-piperazinil-lil-quinolina, con un inhibidor de acetilcolinesterasa para el tratamiento de una enfermedad neurodegenerativa.